Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial.
Saved in:
| Title: | Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial. |
|---|---|
| Authors: | Faridar, Alireza1,2 (AUTHOR) afaridar@houstonmethodist.org, Gamez, Nazaret1 (AUTHOR), Li, Daling1 (AUTHOR), Wang, Yanling1 (AUTHOR), Boradia, Reena1 (AUTHOR), Thome, Aaron D.1 (AUTHOR), Zhao, Weihua1 (AUTHOR), Beers, David R.1 (AUTHOR), Thonhoff, Jason R.1 (AUTHOR), Nakawah, Mohammad O.1 (AUTHOR), Román, Gustavo C.1 (AUTHOR), Volpi, John J.1 (AUTHOR), Toledo, Jon B.1 (AUTHOR), George, Michael3 (AUTHOR), Davis, Charles S.4 (AUTHOR), Pascual, Belen1 (AUTHOR), Grundman, Michael5,6 (AUTHOR), Masdeu, Joseph C.1 (AUTHOR), Appel, Stanley H.1,7 (AUTHOR) sappel@houstonmethodist.org |
| Source: | Alzheimer's Research & Therapy. 7/4/2025, Vol. 17 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
